High-risk superficial bladder cancerKLEIN, Eric A.Seminars in urologic oncology. 1997, Vol 15, Num 3, issn 1081-0943, 61 p.Serial Issue

New techniques in the diagnosis and management of prostate cancerKLEIN, Eric A.Seminars in urology. 1995, Vol 13, Num 2, issn 0730-9147, 78 p.Serial Issue

Superficial bladder cancer : The role of molecular markers in the treatment of high-risk superficial diseaseMALKOWICZ, S. B.Seminars in urologic oncology. 1997, Vol 15, Num 3, pp 169-178, issn 1081-0943Article

The molecular stating of prostate cancerWOOD, D. P.Seminars in urology. 1995, Vol 13, Num 2, pp 96-102, issn 0730-9147Article

Low-dose-rate Brachytherapy as Salvage Treatment of Local Prostate Cancer Recurrence After Radical ProstatectomyTRAUDT, Krystyna; CIEZKI, Jay; KLEIN, Eric A et al.Urology (Ridgewood, NJ). 2011, Vol 77, Num 6, pp 1416-1419, issn 0090-4295, 4 p.Article

Phase II trial of GM-CSF in advanced prostate cancerDREICER, Robert; SEE, William A; KLEIN, Eric A et al.Investigational new drugs. 2001, Vol 19, Num 3, pp 261-265, issn 0167-6997Article

High-risk superficial bladder cancer : Transurethral resection alone in selected patients with T1 tumorHERR, H. W.Seminars in urologic oncology. 1997, Vol 15, Num 3, pp 142-146, issn 1081-0943Article

Combined Androgen Blockade Revisited : Emerging Options for the Treatment of Castration-Resistant Prostate CancerSIMMONS, Matthew N; KLEIN, Eric A.Urology (Ridgewood, NJ). 2009, Vol 73, Num 4, pp 697-705, issn 0090-4295, 9 p.Article

Potential target populations and clinical models for testing chemopreventive agentsKLEIN, Eric A; MEYSKENS, Frank L.Urology (Ridgewood, NJ). 2001, Vol 57, Num 4A, pp 171-173, issn 0090-4295Article

Preliminary observations of single-agent docetaxel as neoadjuvant therapy for locally advanced prostate cancerDREICER, Robert; KLEIN, Eric A.Seminars in oncology. 2001, Vol 28, Num 4, pp 45-48, issn 0093-7754, SUP15Article

Genetic susceptibility and oxidative stress in prostate cancer : Integrated model with implications for preventionKLEIN, Eric A; CASEY, Graham; SILVERMAN, Robert et al.Urology (Ridgewood, NJ). 2006, Vol 68, Num 6, pp 1145-1151, issn 0090-4295, 7 p.Article

Complications of surgery and chemotherapy for testicular cancer : Treatment of patients with testis cancerABOUASSALY, Robert; KLEIN, Eric A; RAGHAVAN, Derek et al.Urologic oncology. 2005, Vol 23, Num 6, pp 447-455, issn 1078-1439, 9 p.Article

Cryosurgical ablation for prostate cancer: a current reviewZIPPE, C. D.Seminars in urology. 1995, Vol 13, Num 2, pp 148-156, issn 0730-9147Article

Localized prostate cancer: radiation or surgery?KLEIN, Eric A; KUPELIAN, Patrick A.Urologic clinics of North America. 2003, Vol 30, Num 2, issn 0094-0143, ix, 315-330 [15 p.]Article

Continent cutaneous urinary diversionROWLAND, R. G.Seminars in urologic oncology. 1997, Vol 15, Num 3, pp 179-183, issn 1081-0943Article

Role of induction androgen deprivation before radical prostatectomySOLOWAY, M. S.Seminars in urology. 1995, Vol 13, Num 2, pp 142-147, issn 0730-9147Article

Deciding whom to biopsyAMLING, Christopher L; CATALONA, William J; KLEIN, Eric A et al.Urologic oncology. 2010, Vol 28, Num 5, pp 542-545, issn 1078-1439, 4 p.Conference Paper

Natural history of biochemical recurrence after radical prostatectomy : Risk assessment for secondary therapySIMMONS, Matthew N; STEPHENSON, Andrew J; KLEIN, Eric A et al.European urology. 2007, Vol 51, Num 5, pp 1175-1184, issn 0302-2838, 10 p.Article

High-risk superficial bladder cancer : Intravesical therapy for T1 G3 transitional cell carcinoma of the urinary bladderPHAM, H. T; SOLOWAY, M. S.Seminars in urologic oncology. 1997, Vol 15, Num 3, pp 147-153, issn 1081-0943Article

Endorectal coil magnetic resonance imaging of prostate cancerMILESTONE, B. N; SEIDMAN, E. J.Seminars in urology. 1995, Vol 13, Num 2, pp 113-121, issn 0730-9147Article

Early intervention or expectant management for prostate cancer. The prostate cancer intervention versus observation trial (PIVOT): a randomized trial comparing radical prostatectomy with expectant management for the treatment of clinically localized prostate cancerWILT, T. J; BRAWER, M. K.Seminars in urology. 1995, Vol 13, Num 2, pp 130-136, issn 0730-9147Article

Alterations of transforming growth factor β receptor II, insulin growth factor receptor II genes in microsatellite unstable prostate carcinomasBHATTACHARYYA, Nandan; JIANMING TAO; KLEIN, Eric A et al.Oncology reports. 2004, Vol 11, Num 1, pp 231-236, issn 1021-335X, 6 p.Article

Sarcomatoid transitional cell carcinoma of bladder managed with transurethral resection aloneNIMEH, Toni; KUANG, Wayne; LEVIN, Howard S et al.The Journal of urology. 2002, Vol 167, Num 2, pp 641-642, issn 0022-5347, 1Article

Management of stage I nonseminomatous germ-cell tumorsTHOMAS, John; ALEMAN, Michael; DREICER, Robert et al.Seminars in urologic oncology. 2002, Vol 20, Num 4, pp 220-226, issn 1081-0943, 7 p.Article

Outcomes for intermediate risk prostate cancer : Are there advantages for surgery, external radiation, or brachytherapy?KLEIN, Eric A; CIEZKI, Jay; KUPELIAN, Patrick A et al.Urologic oncology. 2009, Vol 27, Num 1, pp 67-71, issn 1078-1439, 5 p.Conference Paper